Free Trial

Cellectar Biosciences (CLRB) Short Interest Ratio & Short Volume

$3.11
+0.05 (+1.63%)
(As of 05/24/2024 08:49 PM ET)

Cellectar Biosciences Short Interest Data

Current Short Interest
2,550,000 shares
Previous Short Interest
2,190,000 shares
Change Vs. Previous Month
+16.44%
Dollar Volume Sold Short
$7.88 million
Short Interest Ratio
2.7 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
35,850,000 shares
Float Size
32,470,000 shares
Short Percent of Float
7.85%
Today's Trading Volume
256,400 shares
Average Trading Volume
1,434,898 shares
Today's Volume Vs. Average
18%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cellectar Biosciences ?

Sign up to receive the latest short interest report for Cellectar Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLRB Short Interest Over Time

CLRB Days to Cover Over Time

CLRB Percentage of Float Shorted Over Time

Cellectar Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20242,550,000 shares $7.88 million +16.4%7.9%2.7 $3.09
4/15/20242,190,000 shares $7.27 million -13.4%7.5%2 $3.32
3/31/20242,530,000 shares $10.07 million +34.6%8.7%1.4 $3.98
3/15/20241,880,000 shares $6.54 million -6.5%16.9%1.1 $3.48
2/29/20242,010,000 shares $7.88 million -15.2%17.0%1.2 $3.92
2/15/20242,370,000 shares $8.51 million +25.4%20.1%1.6 $3.59
1/31/20241,890,000 shares $7.39 million +13.2%17.2%1.4 $3.91
1/15/20241,670,000 shares $5.86 million +208.6%15.2%1.5 $3.51
12/31/2023541,100 shares $1.50 million -9.8%4.9%0.6 $2.77
12/15/2023599,900 shares $1.59 million -11.4%5.5%3.2 $2.65
11/30/2023676,700 shares $1.67 million -15.4%6.7%3.9 $2.47
11/15/2023800,100 shares $1.58 million -7.2%6.9%1.1 $1.98
10/31/2023861,800 shares $2.09 million +3.2%9.2%1.3 $2.42
10/15/2023835,300 shares $2.16 million +25.8%8.9%1.3 $2.59
9/30/2023664,100 shares $1.75 million +37.7%7.1%1 $2.64
9/15/2023482,200 shares $1.07 million +238.4%5.2%0.8 $2.21
8/31/2023142,500 shares $252,225.00 -1.8%1.6%0.2 $1.77
8/15/2023145,100 shares $248,121.00 -9.3%1.6%5.7 $1.71
7/31/2023159,900 shares $311,805.00 +15.0%1.7%4.8 $1.95
7/15/2023139,100 shares $255,944.00 +8.9%1.5%3.7 $1.84
6/30/2023127,700 shares $249,015.00 +18.5%1.4%3.3 $1.95
6/15/2023107,800 shares $220,990.00 +29.4%1.2%2.7 $2.05
5/31/202383,300 shares $129,948.00 +2.7%0.9%2.2 $1.56
5/15/202381,100 shares $111,918.00 -7.4%0.9%1.4 $1.38
4/30/202387,600 shares $134,904.00 +25.5%1.0%1.4 $1.54
4/15/202369,800 shares $97,720.00 +47.3%0.8%1.2 $1.40
3/31/202347,400 shares $67,782.00 +4.2%0.5%0.8 $1.43
3/15/202345,500 shares $69,160.00 +237.0%0.5%0.7 $1.52
2/28/202313,500 shares $21,060.00 -49.6%0.2%0.2 $1.56
2/15/202326,800 shares $44,656.84 +8.1%0.3%0.5 $1.67
1/31/202324,800 shares $37,448.00 -40.0%0.3%0.5 $1.51
1/15/202341,300 shares $70,416.50 +50.7%0.5%0.7 $1.71
12/30/202227,400 shares $46,854.00 +144.6%0.3%0.5 $1.71
12/15/202211,200 shares $15,344.00 -9.7%0.1%0.2 $1.37
11/30/202212,400 shares $23,312.00 +53.1%0.1%0.3 $1.88
11/15/20228,100 shares $15,309.00 -16.5%0.1%0.2 $1.89
10/31/20229,700 shares $19,594.00 +61.7%0.1%0.3 $2.02
10/15/20226,000 shares $12,540.00 -1.6%0.1%0.2 $2.09
9/30/20226,100 shares $20,496.00 -28.2%0.1%0.2 $3.36
9/15/20228,500 shares $40,460.00 +6.3%0.2%0.4 $4.76
Protect Your Bank Account Before It’s Too Late (Ad)

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself
8/31/20228,000 shares $43,872.00 -64.8%0.1%0.3 $5.48
8/15/202222,700 shares $141,875.00 +59.9%0.4%0.9 $6.25
7/31/202214,200 shares $55,664.00 +647.4%0.3%0.6 $3.92
7/15/20221,900 shares $8,168.08 +111.1%N/A0.1 $4.30
6/30/20229,200 shares $3,716.80 -55.3%0.2%0.1 $0.40
6/15/202220,600 shares $7,698.22 -61.5%0.4%0.1 $0.37
5/31/202253,500 shares $21,935.00 +2.9%N/A0.3 $0.41
5/15/202252,000 shares $19,760.00 +112.2%N/A0.3 $0.38
4/30/202224,500 shares $13,107.50 -55.7%N/A0.1 $0.54
4/15/202255,300 shares $38,079.58 -74.2%N/A0.3 $0.69
3/31/2022214,700 shares $147,670.66 +70.1%N/A1.1 $0.69
3/15/2022126,200 shares $59,440.20 +10.8%N/A0.5 $0.47
2/28/2022113,900 shares $58,145.95 -43.1%N/A0.4 $0.51
2/15/2022200,100 shares $110,455.20 -14.4%N/A0.6 $0.55
1/31/2022233,800 shares $140,280.00 +283.9%N/A0.7 $0.60
1/15/202260,900 shares $42,563.01 +138.8%N/A0.2 $0.70
12/31/202125,500 shares $16,932.00 -74.6%N/A0.1 $0.66
12/15/2021100,500 shares $68,048.55 -32.7%N/A0.3 $0.68
11/30/2021149,300 shares $103,166.30 +112.1%N/A0.4 $0.69
11/15/202170,400 shares $59,368.32 -27.9%N/A0.2 $0.84
10/29/202197,700 shares $84,217.40 -38.4%N/A0.2 $0.86
10/15/2021158,700 shares $145,543.77 -85.2%N/A0.3 $0.92
9/30/20211,070,000 shares $989,750.00 +2.9%N/A1.4 $0.93
9/15/20211,040,000 shares $1.02 million -4.6%N/A1.2 $0.98
8/31/20211,090,000 shares $1.11 million -16.2%N/A1.1 $1.02
8/13/20211,300,000 shares $1.13 million -13.3%N/A1.3 $0.87
7/30/20211,500,000 shares $1.64 million -5.7%3.2%1.8 $1.09
7/15/20211,590,000 shares $1.67 million +40.7%3.4%2.1 $1.05
6/30/20211,130,000 shares $1.34 million -26.1%2.4%1.6 $1.19
6/15/20211,530,000 shares $2.00 million -12.1%3.2%2.6 $1.31
5/28/20211,740,000 shares $2.85 million +4.8%3.7%2.5 $1.64
5/14/20211,660,000 shares $2.08 million -11.7%N/A1.9 $1.25
4/30/20211,880,000 shares $2.91 million +2.2%N/A1.4 $1.55
4/15/20211,840,000 shares $2.74 million -13.2%N/A1.1 $1.49
3/31/20212,120,000 shares $3.26 million -1.4%N/A1.1 $1.54
3/15/20212,150,000 shares $4.19 million -9.3%N/A0.9 $1.95
2/26/20212,370,000 shares $4.67 million +2.6%N/A0.9 $1.97
2/12/20212,310,000 shares $5.73 million +4.1%N/A0.8 $2.48
1/29/20212,220,000 shares $3.95 million -1.3%N/A0.9 $1.78
1/15/20212,250,000 shares $4.61 million -11.1%N/A1.1 $2.05
12/31/20202,530,000 shares $5.44 million -4.2%N/A1.4 $2.15
12/15/20202,640,000 shares $5.46 million +161.4%N/A1.7 $2.07
11/30/20201,010,000 shares $1.24 million -3.8%N/A1.1 $1.23
11/15/20201,050,000 shares $1.19 million -2.8%N/A3.9 $1.13
10/30/20201,080,000 shares $1.29 million +4.9%N/A2.8 $1.19
10/15/20201,030,000 shares $1.30 million -1.0%N/A1.6 $1.26
9/30/20201,040,000 shares $1.29 million +1.0%N/A1.4 $1.24
9/15/20201,030,000 shares $1.28 million -8.0%N/A1.2 $1.24
8/31/20201,120,000 shares $1.33 million +6.7%N/A1.2 $1.19
8/14/20201,050,000 shares $1.50 million -6.3%N/A0.8 $1.43
Protect Your Bank Account Before It’s Too Late (Ad)

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself
7/31/20201,120,000 shares $1.69 million +284.2%N/A1 $1.51
7/15/2020291,500 shares $411,015.00 +213.4%N/A0.3 $1.41
6/30/202093,000 shares $120,900.00 +54.7%N/A0.1 $1.30
6/15/202060,100 shares $70,918.00 -94.1%N/A0.1 $1.18
5/29/20201,010,000 shares $1.53 million +1,681.3%N/A2 $1.51
5/15/202056,700 shares $82,215.00 +6,200.0%0.7%0.4 $1.45
4/30/2020900 shares $1,535.40 -76.3%0.0%0 $1.71
4/15/20203,800 shares $6,213.76 -92.9%0.0%0 $1.64
3/31/202053,300 shares $77,818.00 -86.3%0.6%0.3 $1.46
3/13/2020388,100 shares $539,459.00 -9.2%4.3%4.9 $1.39
2/28/2020427,200 shares $508,368.00 +13.3%4.8%2.5 $1.19
2/14/2020377,100 shares $757,971.00 +6.3%4.2%2.2 $2.01
1/31/2020354,900 shares $798,525.00 +13.8%4.0%2.9 $2.25
1/15/2020311,900 shares $842,130.00 +88.9%3.4%2.5 $2.70
12/31/2019165,100 shares $432,562.00 -30.4%1.8%1.3 $2.62
8/15/2019403,300 shares $863,062.00 -5.3%8.7%0.9 $2.14

CLRB Short Interest - Frequently Asked Questions

What is Cellectar Biosciences' current short interest?

Short interest is the volume of Cellectar Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,550,000 shares of CLRB short. 7.85% of Cellectar Biosciences' shares are currently sold short. Learn More on Cellectar Biosciences' current short interest.

What is a good short interest ratio for Cellectar Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLRB shares currently have a short interest ratio of 3.0. Learn More on Cellectar Biosciences's short interest ratio.

Which institutional investors are shorting Cellectar Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cellectar Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cellectar Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.85% of Cellectar Biosciences' floating shares are currently sold short.

Is Cellectar Biosciences' short interest increasing or decreasing?

Cellectar Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,550,000 shares, an increase of 16.4% from the previous total of 2,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cellectar Biosciences' float size?

Cellectar Biosciences currently has issued a total of 35,850,000 shares. Some of Cellectar Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellectar Biosciences currently has a public float of 32,470,000 shares.

How does Cellectar Biosciences' short interest compare to its competitors?

7.85% of Cellectar Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cellectar Biosciences: DiaMedica Therapeutics Inc. (0.48%), Abeona Therapeutics Inc (12.94%), Vistagen Therapeutics, Inc. (4.86%), FibroGen, Inc. (6.96%), Immunic, Inc. (3.13%), Adagene Inc. (0.04%), CervoMed Inc. (1.06%), Rezolute, Inc. (0.78%), Coya Therapeutics, Inc. (1.41%), Nuvectis Pharma, Inc. (13.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Cellectar Biosciences stock?

Short selling CLRB is an investing strategy that aims to generate trading profit from Cellectar Biosciences as its price is falling. CLRB shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cellectar Biosciences?

A short squeeze for Cellectar Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLRB, which in turn drives the price of the stock up even further.

How often is Cellectar Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLRB, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CLRB) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners